Panel Discussion | Who Should get MCS for High-Risk PCI and with Which Device?

Sunday, February 26, 2023

9:41 AM – 10:00 AM ET

Panel Moderator(s)

David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)
Jeffrey W. Moses, MD, FSCAI

John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States

Disclosure(s): Covanos: Stock-privately held company (Ongoing); Orchestra Biomed: Stock-privately held company (Ongoing); Ostial: Stock-privately held company (Ongoing); Weightless Lead: Stock-privately held company (Ongoing); Xenter: Stock-privately held company (Ongoing)
Samin K. Sharma, MD

Senior Vice-President, Operations & Quality
Mount Sinai Hospital
New York, New York, United States

No relationships to disclose

Panel Discussant(s)

James C. Blankenship, MD, MHCM, MSCAI, MACC

Director of Cardiology, University of New Mexico
University of New Mexico
Danville, Pennsylvania, United States

No relationships to disclose
Taishi Hirai, MD

Assistant Professor of Clinical Medicine
University of Missouri
Columbia, Missouri, United States

Disclosure(s): Ashi intecc: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Siemens/Corindus: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zeon Medical: Consultant (Ongoing)
Anita R. Krueger, MD

Cardiothoracic Surgeon
Baylor Scott & White-All Saints Medical Center
Fort Worth, Texas, United States

Disclosure(s): Baylor Heart and Vascular Hospital: Shareholder (Ongoing)
Vinoy S. Prasad, MD, FACC, FSCAI

Director of Interventional Cardiology
Loma Linda University Medical Center
Redlands, California, United States

No relationships to disclose
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)
Robert W. Yeh, MD, MSc

Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott Vasular, Boston Scientific, MEdtronic: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Industry Grant Support (Ongoing); Bard, Cook, Philips: Grant/Research Support (Ongoing); Elixir Medical, Shockwave, Zoll, Cathworkd: Consultant (Ongoing)

Disclosure(s):

David E. Kandzari, MD, FACC, FSCAI: Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

Jeffrey W. Moses, MD, FSCAI: Covanos: Stock-privately held company (Ongoing); Orchestra Biomed: Stock-privately held company (Ongoing); Ostial: Stock-privately held company (Ongoing); Weightless Lead: Stock-privately held company (Ongoing); Xenter: Stock-privately held company (Ongoing)

Taishi Hirai, MD: Ashi intecc: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Siemens/Corindus: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zeon Medical: Consultant (Ongoing)

Anita R. Krueger, MD: Baylor Heart and Vascular Hospital: Shareholder (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)

Nicolas M. Van Mieghem, MD, PhD, FESC, FACC: Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

Robert W. Yeh, MD, MSc: Abbott Vasular, Boston Scientific, MEdtronic: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Industry Grant Support (Ongoing); Bard, Cook, Philips: Grant/Research Support (Ongoing); Elixir Medical, Shockwave, Zoll, Cathworkd: Consultant (Ongoing)